Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Bergman

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Thrombosis and Haemostasis|January 1, 1996
Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia BA D Shapiro, M V Ragni, J M Lusher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 22, 2011
Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgeryJ Di Paola, S Lethagen, J Gill, et al.
Lancet (London, England)|September 18, 1993
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune statusS V Seremetis, L M Aledort, G E Bergman, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Thrombosis and Haemostasis|January 1, 1996
Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia BA D Shapiro, M V Ragni, J M Lusher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 22, 2011
Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgeryJ Di Paola, S Lethagen, J Gill, et al.
Lancet (London, England)|September 18, 1993
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune statusS V Seremetis, L M Aledort, G E Bergman, et al.
Pageof 4